Home > > > > > Report Detail

Diabetic foot ulcers (DFUs) - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Diabetic foot ulcers (DFUs) - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Diabetic foot ulcers (DFUs) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Diabetic foot ulcers (DFUs) Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Diabetic foot ulcers (DFUs) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Diabetic foot ulcers (DFUs) outlook. It also includes the explanation of changing trends of epidemiology outlining the Diabetic foot ulcers (DFUs) scenario.

Diabetic foot ulcers (DFUs) Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Diabetic foot ulcers (DFUs) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Diabetic foot ulcers (DFUs) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Diabetic foot ulcers (DFUs) Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Diabetic foot ulcers (DFUs)

Key assessments

- Patient Segmentation in Diabetic foot ulcers (DFUs)

- Diabetic foot ulcers (DFUs) Risk & Burden

- Factors driving growth in a specific Diabetic foot ulcers (DFUs) patient population

Diabetic foot ulcers (DFUs) - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Diabetic foot ulcers (DFUs) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Diabetic foot ulcers (DFUs) in 2016
2.2. Patient Share Distribution of Diabetic foot ulcers (DFUs) in 2028
3. Disease Background and Overview: Diabetic foot ulcers (DFUs)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Diabetic foot ulcers (DFUs) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Diabetic foot ulcers (DFUs) in 7MM - By Countries
5. Epidemiology of Diabetic foot ulcers (DFUs) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs)
5.1.3. Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) *
5.1.4. Sex- Specific Cases of the Diabetic foot ulcers (DFUs)*
5.1.5. Diagnosed Cases of the Diabetic foot ulcers (DFUs)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs)
5.4.3. Sub-Type Specific cases of the Diabetic foot ulcers (DFUs)*
5.4.4. Sex- Specific Cases of the Diabetic foot ulcers (DFUs)*
5.4.5. Diagnosed Cases of the Diabetic foot ulcers (DFUs)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs)
5.5.3. Sub-Type Specific cases of the Diabetic foot ulcers (DFUs)*
5.5.4. Sex- Specific Cases of the Diabetic foot ulcers (DFUs)*
5.5.5. Diagnosed Cases of the Diabetic foot ulcers (DFUs)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs)
5.6.3. Sub-Type Specific cases of the Diabetic foot ulcers (DFUs)*
5.6.4. Sex- Specific Cases of the Diabetic foot ulcers (DFUs)*
5.6.5. Diagnosed Cases of the Diabetic foot ulcers (DFUs)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs)
5.7.3. Sub-Type Specific cases of the Diabetic foot ulcers (DFUs)*
5.7.4. Sex- Specific Cases of the Diabetic foot ulcers (DFUs)*
5.7.5. Diagnosed Cases of the Diabetic foot ulcers (DFUs)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs)
5.8.3. Sub-Type Specific cases of the Diabetic foot ulcers (DFUs)*
5.8.4. Sex- Specific Cases of the Diabetic foot ulcers (DFUs)*
5.8.5. Diagnosed Cases of the Diabetic foot ulcers (DFUs)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs)
5.9.3. Sub-Type Specific cases of the Diabetic foot ulcers (DFUs)*
5.9.4. Sex- Specific Cases of the Diabetic foot ulcers (DFUs)*
5.9.5. Diagnosed Cases of the Diabetic foot ulcers (DFUs)
6. Unmet Needs of the Diabetic foot ulcers (DFUs)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in 7MM
Table 2: Total Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in France (2016-2028) *
Table 14: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Diabetic foot ulcers (DFUs) in Japan (2016-2028)

  • Global Glycated Albumin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Glycated Albumin market size was valued at US$ 419.7 million in 2023. With growing demand in downstream market, the Glycated Albumin is forecast to a readjusted size of US$ 593.8 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Glycated Albumin market. Glycated Albumin are expected to show stable growth in the future market. However, product differenti......
  • Global Neuropathy Pain Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Neuropathy Pain Treatment market size was valued at US$ 8341.5 million in 2023. With growing demand in downstream market, the Neuropathy Pain Treatment is forecast to a readjusted size of US$ 10560 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Neuropathy Pain Treatment market. Neuropathy Pain Treatment are expected to show stable growth in the futur......
  • Global Neuropathy Pain Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 92
    According to our (Global Info Research) latest study, the global Neuropathy Pain Treatment market size was valued at USD 8773.9 million in 2023 and is forecast to a readjusted size of USD 10910 million by 2030 with a CAGR of 3.2% during review period. This report studies the Neuropathy Pain Treatment market, Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain. Global Neuropath......
  • Global Type 1 Diabetes Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Type 1 Diabetes Therapeutics market: According to our latest research, the global Type 1 Diabetes Therapeutics market looks promising in the next 5 years. As of 2022, the global Type 1 Diabetes Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in w......
  • Global Diabetic Neuropathy Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 104
    Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......
  • Global Diabetic Neuropathy Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......
  • Global Diabetic Nephropathy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 23-Nov-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Diabetic Nephropathy market: According to our latest research, the global Diabetic Nephropathy market looks promising in the next 5 years. As of 2022, the global Diabetic Nephropathy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Diabetic nephropathy (DN) is a chronic loss of renal function in diabetic patients. This report covers a research ti......
  • Global Glycated Albumin Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......
  • Global Glycated Albumin Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 106
    Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs